AI avatars take on patient education: can they beat Old-School slides?

NCT ID NCT07550686

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI-generated avatar video helps radiotherapy patients understand their treatment and feel less anxious, compared to a standard slide-based video. About 136 patients will watch one of the two videos and answer questionnaires. The goal is to see if the AI approach improves patient education and reduces pre-treatment worry.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-based educational video

What this could lead to

If successful, this could show that AI avatar videos are a better way to educate patients before radiotherapy, potentially reducing anxiety and improving understanding.

What could go wrong

This is a small, early-stage study (136 participants) comparing two video formats. The results may not apply to all patients or settings, and the AI video may not be more effective than the standard one.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Yongin Severance Hospital

    RECRUITING

    Yongin-si, 365, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••